Trials / Conditions / Stage 0 Chronic Lymphocytic Leukemia

Stage 0 Chronic Lymphocytic Leukemia

11 registered clinical trials studyying Stage 0 Chronic Lymphocytic Leukemia.

Status	Trial	Sponsor	Phase
Terminated	Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Sm NCT02309515	Mayo Clinic	Phase 2
Completed	Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leu NCT02100423	Paolo Caimi, MD	Phase 2
Completed	Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphom NCT02213913	University of Chicago	Phase 1 / Phase 2
Active Not Recruiting	Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukem NCT01351896	National Cancer Institute (NCI)	Phase 2
Completed	Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia NCT01269385	Mayo Clinic	Phase 1 / Phase 2
Active Not Recruiting	Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic NCT01199562	City of Hope Medical Center	—
Completed	Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Canc NCT01053494	Wake Forest University Health Sciences	N/A
Completed	Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia NCT01024010	Mayo Clinic	Phase 2
Terminated	Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Le NCT01649791	Roswell Park Cancer Institute	N/A
Completed	Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chro NCT00563290	National Cancer Institute (NCI)	Phase 2
Completed	Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenola NCT00112593	Fred Hutchinson Cancer Center	N/A